For analyzing the involvement of imidazolone in the chronic disease

Anti 3-DG-imidazolone Monoclonal Antibody


print

Background

It has been shown that Advanced Glycation End products (AGE) have been involved in chronic disease with aging, such as diabetes or brain disease. So far, several AGE structure has been identified, and these studies shed light on the important role of the growth of the disease.
Imidazolone is one of AGE structure, and has been shown that there are two pathways to generate. One is through 3-deoxyglucosone (3-DG) and another is through methlglyoxal. But it is not clear which pathway is dominant in each chronic disease.
This antibody is very useful for analyzing the involvement of imidazolone in the chronic disease.


 AGEs Antibody Flyer [PDF]
 AGEs Antibody Flyer@(print file) [PDF]
References

> Noriyuki Shibata et al,. Acta Neuropathol Vol.100. 275-284 (2000)

Product List

Product Name Cat# Quantity Price

Anti 3-DG-Imidazolone, - (Mouse) Unlabeled DataSheet

KAL-KH043

50 UG ¥55,000
$734

“Anti 3-DG-imidazolone Monoclonal Antibody” also belongs to the following categories.